Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Daniel D. Billadeau, Ph.D.

By Nicole Ferrara • December 11, 2019
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials SPORE
Subscribe
Request an Appointment
Find a Clinical Trial
Pancreatic cancer: Risk, treatment and clinical trials

Dr. Robert McWilliams discusses who's at risk for pancreatic cancer, the need for aggressive treatment and the hope clinical trials offer.

Advancing pancreatic cancer treatment with total robotic Whipple surgery

Dr. Zhi Ven Fong discusses innovations in the Whipple procedure, a complex surgery for cancer that hasn't spread beyond the pancreas.

Detecting pancreatic cancer through changes in body composition and metabolism

New Mayo Clinic research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection.